Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.72 |
| ▸ | FAAH | O00519 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.69 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.69 |
| ▸ | THRB | P10828 | 1/20 | 0.69 |
| ▸ | CNR2 | P34972 | 1/20 | 0.69 |
| ▸ | BLM | P54132 | 1/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.69 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.69 |
| ▸ | CNR1 | P21554 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22758117 | 1.00 | MEN1 (0.72) | MEN1KMT2AFAAHMAPK1ALDH1A1 | |
| SCHEMBL6534948 | 0.95 | CNR2 (0.76) | ALDH1A1SMN1; SMN2KCNK3THRBCNR2 | |
| SCHEMBL6903752 | 0.95 | FAAH (0.79) | MEN1KMT2AFAAHMAPK1ALDH1A1 | |
| SCHEMBL1456866 | 0.95 | FAAH (0.79) | MEN1KMT2AFAAHMAPK1ALDH1A1 | |
| SCHEMBL1456449 | 0.95 | FAAH (0.79) | MEN1KMT2AFAAHMAPK1ALDH1A1 | |
| SCHEMBL5682652 | 0.89 | ALDH1A1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2KCNK3 | |
| SCHEMBL5145799 | 0.89 | ALDH1A1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2KCNK3 | |
| SCHEMBL653624 | 0.89 | ALDH1A1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2KCNK3 | |
| SCHEMBL11872018 | 0.89 | ALDH1A1 (0.68) | MEN1KMT2AALDH1A1SMN1; SMN2KCNK3 | |
| SCHEMBL15285515 | 0.87 | SMN1; SMN2 (0.92) | MEN1KMT2AFAAHALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | Arrowhead Pharmaceuticals, Inc. | 2023-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230226193-A1 | LIPID CONJUGATES FOR THE DELIVERY OF THERAPEUTIC AGENTS | CPT1B, MUSK, MYLK2 | MEN1 4753/4885KMT2A 1603/4885FAAH 2901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.